This report is an updated version of the report published on 10 August 2023 at 07:45 AM GMT+1.

Section 1: Company Overview and Fundamental Insights

1.1 Company Overview:

Craneware PLC (LSE: CRW) is an FTSE AIM 100 index listed entity that provides software and solutions to improve financial performance for healthcare organizations. Kalkine’s HealthCare Report covers the Investment Highlights, Key Financial Metrics, Risks, Recent Business Updates along with the Valuation, Target Price, and Recommendation on the stock.

CRW will release FY23 results for the year ended 30 June 2023 on 5 September 2023.

1.2 The Key Positives, Negatives, Highlights and Risks

1.3 Top 10 Shareholders:

The top 10 shareholders collectively form ~57.02% of the total shareholdings. Liontrust Investment Partners LLP holds the maximum number of shares with ~12.92% shareholding, followed by Neilson (Keith) with ~9.76% shareholding, as depicted in the chart below: 

1.4 Key Metrics:

Section 2:  Business Updates and Financial Highlights

2.1 Recent Business Updates

2.2 H1 FY23 Financial Highlights (for the 6 months ended 31 December 2022, as of 06 March 2023)

Section 3:  Key Risks and Outlook

Section 4: Stock Recommendation Summary

4.1 Price Performance and Technical Summary:

The stock has witnessed a decline of ~6.44% in the last one month and over the last 6 months, it has decreased by ~9.83%. The stock has a 52-week low and 52-week high of GBX 1,060.00 & GBX 2,250.00, respectively and is currently trading below the average of 52-week high-low.

4.2 Fundamental Valuation

Valuation Methodology: Price/Earnings Approach

Please note markets are trading in a highly volatile zone currently due to certain macro-economic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is 09 August 2023. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5:  Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Note 6: Dividend Yield may vary as per the stock price movement.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.